hFCRN/hALB(SD)
品系全名
SD-Fcgrtem1(hFCGRT)Albem3(hALB)Smoc
目錄號(hào)
NR-HU-233317
品系狀態(tài)
活體
基因信息
基因名
品系描述
驗(yàn)證數(shù)據(jù)
Fig.1 Detection of ALB expression in serum by blood biochemical analysis (n=4).?
Abbr. HO, homozygous; WT, wild type.
Fig.2 Detection of hALB (A) and rALB (B) expression in serum by ELISA (n=3).?
Abbr. HO, homozygous; WT, wild type.
Fig.3 Expression characterization of hFCRN in hALB/hFCRN dKI rat by Western blot. (Arrow indicates expected molecular weight and asterisk indicates a nonspecific band)? ?
Fig.4? Blood concentration curve of test articles in hFcRn/hALB dKI rats.?
In hFcRn/hALB dKI rats, the half-life time: TA-N434A > TA-YTE > TA. (In cooperation with the third party)?
Fig.5 PK study of Keytruda in? hALB/hFCRN dKl rat. (n=3/time point/group)??
Fig.6 PK study of Cyramza in hALB/hFCRN dKI rat. (n=3/time point/group)??
你也可能感興趣
Cre-ERT2在無(wú)Tamoxifen誘導(dǎo)的情況下，在細(xì)胞質(zhì)內(nèi)處于無(wú)活性狀態(tài)；當(dāng)Tamoxifen誘導(dǎo)后，Tamoxifen的代謝產(chǎn)物4-OHT（雌激素類似物）與ERT結(jié)合，可使Cre-ERT2進(jìn)核發(fā)揮Cre重組酶活性。
查看常見的基因工程小鼠可以分為兩種命名方式，包括基因定點(diǎn)修飾的小鼠命名，比如：敲除、敲入、點(diǎn)突變等等，和隨機(jī)轉(zhuǎn)基因的小鼠命名。
查看
